Trileptal Side Effects Injury Lawsuits. Trileptal (Generic: Oxcarbazepine) is an antiepileptic drug that has been approved by the U.S. Food and Drug Administration and is indicated for use as monotherapy (by itself) or adjunctive therapy (taken with other medications) in the treatment of partial seizures in adults and children 4 years of age and older with epilepsy.
Novartis Pharmaceuticals and the FDA notified healthcare professionals about revisions to the warnings and precautions sections of the prescribing information for Trileptal tablets and oral suspension. The updated warnings section describes serious dermatological reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), that have been reported in both children and adults in association with Trileptal use.
Multi-organ Hypersensitivity Reactions
The PRECAUTIONS section has been updated to include language regarding multi-organ hypersensitivity reactions that have been reported in association with Trileptal use. Trileptal has been available in the United States since February 2000, and has been prescribed for over 250,000 patients. In 2004, sales of Trileptal totaled $391 million.